APO Research
Talk to an analyst

APO RESEARCH · REPORT

Somatostatin and Somatostatin Analogs

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Somatostatin and Somatostatin Analogs Industry Growth and Trends Forecast to 2032

2 January 202697 pages

Choose your research edition.

Industry ResearchSomatostatin and Somatostatin Analogs Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Somatostatin and Somatostatin Analogs Industry Growth and Trends Forecast to 203297 pages · $3,450 USDMarket StructureGlobal Somatostatin and Somatostatin Analogs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032189 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Somatostatin and Somatostatin Analogs Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Somatostatin and Somatostatin Analogs Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Somatostatin and Somatostatin Analogs market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Somatostatin and Somatostatin Analogs is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Somatostatin and Somatostatin Analogs is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Somatostatin and Somatostatin Analogs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Somatostatin and Somatostatin Analogs include Novartis, Pfizer, TianTaiShan, Ispen and HYBIO, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Somatostatin and Somatostatin Analogs market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Somatostatin and Somatostatin Analogs market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Somatostatin and Somatostatin Analogs market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Somatostatin and Somatostatin Analogs.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Somatostatin and Somatostatin Analogs market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Somatostatin and Somatostatin Analogs Market by Company

Novartis

Pfizer

TianTaiShan

Ispen

HYBIO

Somatostatin and Somatostatin Analogs Segment by Type

Octreotide

Lanreotide

Pasireotide

Other

Somatostatin and Somatostatin Analogs Segment by Application

Hospital

Pharmacy

Other

Somatostatin and Somatostatin Analogs Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Somatostatin and Somatostatin Analogs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Somatostatin and Somatostatin Analogs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Somatostatin and Somatostatin Analogs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Somatostatin and Somatostatin Analogs manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Somatostatin and Somatostatin Analogs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Octreotide Table 2. Major Company of Lanreotide Table 3. Major Company of Pasireotide Table 4. Major Company of Other Table 5. Global Somatostatin and Somatostatin Analogs Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 6. Global Somatostatin and Somatostatin Analogs Sales by Type (2021-2026) & (K Units) Table 7. Global Somatostatin and Somatostatin Analogs Sales Market Share in Volume by Type (2021-2026) Table 8. Global Somatostatin and Somatostatin Analogs Sales by Type (2021-2026) & (US$ Million) Table 9. Global Somatostatin and Somatostatin Analogs Sales Market Share in Value by Type (2021-2026) Table 10. Global Somatostatin and Somatostatin Analogs Price by Type (2021-2026) & (US$/Unit) Table 11. Global Somatostatin and Somatostatin Analogs Sales by Type (2027-2032) & (K Units) Table 12. Global Somatostatin and Somatostatin Analogs Sales Market Share in Volume by Type (2027-2032) Table 13. Global Somatostatin and Somatostatin Analogs Sales by Type (2027-2032) & (US$ Million) Table 14. Global Somatostatin and Somatostatin Analogs Sales Market Share in Value by Type (2027-2032) Table 15. Global Somatostatin and Somatostatin Analogs Price by Type (2027-2032) & (US$/Unit) Table 16. North America Somatostatin and Somatostatin Analogs Sales by Type (2021-2026) & (K Units) Table 17. North America Somatostatin and Somatostatin Analogs Sales by Type (2021-2026) & (US$ Million) Table 18. Europe Somatostatin and Somatostatin Analogs Sales by Type (2021-2026) & (K Units) Table 19. Europe Somatostatin and Somatostatin Analogs Sales by Type (2021-2026) & (US$ Million) Table 20. Asia-Pacific Somatostatin and Somatostatin Analogs Sales by Type (2021-2026) & (K Units) Table 21. Asia-Pacific Somatostatin and Somatostatin Analogs Sales by Type (2021-2026) & (US$ Million) Table 22. Latin America Somatostatin and Somatostatin Analogs Sales by Type (2021-2026) & (K Units) Table 23. Latin America Somatostatin and Somatostatin Analogs Sales by Type (2021-2026) & (US$ Million) Table 24. Middle East and Africa Somatostatin and Somatostatin Analogs Sales by Type (2021-2026) & (K Units) Table 25. Middle East and Africa Somatostatin and Somatostatin Analogs Sales by Type (2021-2026) & (US$ Million) Table 26. Somatostatin and Somatostatin Analogs Industry Trends Table 27. Somatostatin and Somatostatin Analogs Industry Drivers Table 28. Somatostatin and Somatostatin Analogs Industry Opportunities and Challenges Table 29. Somatostatin and Somatostatin Analogs Industry Restraints Table 30. Global Somatostatin and Somatostatin Analogs Sales Revenue by Company (US$ Million) & (2021-2026) Table 31. Global Somatostatin and Somatostatin Analogs Revenue Market Share by Company (2021-2026) Table 32. Global Somatostatin and Somatostatin Analogs Sales by Company (2021-2026) & (K Units) Table 33. Global Somatostatin and Somatostatin Analogs Sales Share by Company (2021-2026) Table 34. Global Somatostatin and Somatostatin Analogs Market Price by Company (2021-2026) & (US$/Unit) Table 35. Global Somatostatin and Somatostatin Analogs Industry Company Ranking, 2024 VS 2025 VS 2026 Table 36. Global Somatostatin and Somatostatin Analogs Major Company Production Sites and Headquarters Table 37. Global Somatostatin and Somatostatin Analogs Company, Product Type & Application Table 38. Global Somatostatin and Somatostatin Analogs Company Establishment Date Table 39. Global Company Market Concentration Ratio (CR5 and HHI) Table 40. Global Somatostatin and Somatostatin Analogs by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 41. Global Somatostatin and Somatostatin Analogs Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 42. Global Somatostatin and Somatostatin Analogs Sales by Region (2021-2026) & (K Units) Table 43. Global Somatostatin and Somatostatin Analogs Sales Market Share in Volume by Region (2021-2026) Table 44. Global Somatostatin and Somatostatin Analogs Sales by Region (2021-2026) & (US$ Million) Table 45. Global Somatostatin and Somatostatin Analogs Sales Market Share in Value by Region (2021-2026) Table 46. Global Somatostatin and Somatostatin Analogs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 47. Global Somatostatin and Somatostatin Analogs Sales by Region (2027-2032) & (K Units) Table 48. Global Somatostatin and Somatostatin Analogs Sales Market Share in Volume by Region (2027-2032) Table 49. Global Somatostatin and Somatostatin Analogs Sales by Region (2027-2032) & (US$ Million) Table 50. Global Somatostatin and Somatostatin Analogs Sales Market Share in Value by Region (2027-2032) Table 51. Global Somatostatin and Somatostatin Analogs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 52. Global Somatostatin and Somatostatin Analogs Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 53. Global Somatostatin and Somatostatin Analogs Sales by Application (2021-2026) & (K Units) Table 54. Global Somatostatin and Somatostatin Analogs Sales Market Share in Volume by Application (2021-2026) Table 55. Global Somatostatin and Somatostatin Analogs Sales by Application (2021-2026) & (US$ Million) Table 56. Global Somatostatin and Somatostatin Analogs Sales Market Share in Value by Application (2021-2026) Table 57. Global Somatostatin and Somatostatin Analogs Price by Application (2021-2026) & (US$/Unit) Table 58. Global Somatostatin and Somatostatin Analogs Sales by Application (2027-2032) & (K Units) Table 59. Global Somatostatin and Somatostatin Analogs Sales Market Share in Volume by Application (2027-2032) Table 60. Global Somatostatin and Somatostatin Analogs Sales by Application (2027-2032) & (US$ Million) Table 61. Global Somatostatin and Somatostatin Analogs Sales Market Share in Value by Application (2027-2032) Table 62. Global Somatostatin and Somatostatin Analogs Price by Application (2027-2032) & (US$/Unit) Table 63. North America Somatostatin and Somatostatin Analogs Sales by Application (2021-2026) & (K Units) Table 64. North America Somatostatin and Somatostatin Analogs Sales by Application (2021-2026) & (US$ Million) Table 65. Europe Somatostatin and Somatostatin Analogs Sales by Application (2021-2026) & (K Units) Table 66. Europe Somatostatin and Somatostatin Analogs Sales by Application (2021-2026) & (US$ Million) Table 67. Asia-Pacific Somatostatin and Somatostatin Analogs Sales by Application (2021-2026) & (K Units) Table 68. Asia-Pacific Somatostatin and Somatostatin Analogs Sales by Application (2021-2026) & (US$ Million) Table 69. Latin America Somatostatin and Somatostatin Analogs Sales by Application (2021-2026) & (K Units) Table 70. Latin America Somatostatin and Somatostatin Analogs Sales by Application (2021-2026) & (US$ Million) Table 71. Middle East and Africa Somatostatin and Somatostatin Analogs Sales by Application (2021-2026) & (K Units) Table 72. Middle East and Africa Somatostatin and Somatostatin Analogs Sales by Application (2021-2026) & (US$ Million) Table 73. Novartis Company Information Table 74. Novartis Business Overview Table 75. Novartis Somatostatin and Somatostatin Analogs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. Novartis Somatostatin and Somatostatin Analogs Product Portfolio Table 77. Novartis Recent Development Table 78. Pfizer Company Information Table 79. Pfizer Business Overview Table 80. Pfizer Somatostatin and Somatostatin Analogs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. Pfizer Somatostatin and Somatostatin Analogs Product Portfolio Table 82. Pfizer Recent Development Table 83. TianTaiShan Company Information Table 84. TianTaiShan Business Overview Table 85. TianTaiShan Somatostatin and Somatostatin Analogs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. TianTaiShan Somatostatin and Somatostatin Analogs Product Portfolio Table 87. TianTaiShan Recent Development Table 88. Ispen Company Information Table 89. Ispen Business Overview Table 90. Ispen Somatostatin and Somatostatin Analogs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. Ispen Somatostatin and Somatostatin Analogs Product Portfolio Table 92. Ispen Recent Development Table 93. HYBIO Company Information Table 94. HYBIO Business Overview Table 95. HYBIO Somatostatin and Somatostatin Analogs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. HYBIO Somatostatin and Somatostatin Analogs Product Portfolio Table 97. HYBIO Recent Development Table 98. North America Somatostatin and Somatostatin Analogs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 99. North America Somatostatin and Somatostatin Analogs Sales by Country (2021-2026) & (K Units) Table 100. North America Somatostatin and Somatostatin Analogs Sales Market Share by Country (2021-2026) Table 101. North America Somatostatin and Somatostatin Analogs Sales Forecast by Country (2027-2032) & (K Units) Table 102. North America Somatostatin and Somatostatin Analogs Sales Market Share Forecast by Country (2027-2032) Table 103. North America Somatostatin and Somatostatin Analogs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 104. North America Somatostatin and Somatostatin Analogs Market Size by Country (2021-2026) & (US$ Million) Table 105. North America Somatostatin and Somatostatin Analogs Market Share by Country (2021-2026) Table 106. North America Somatostatin and Somatostatin Analogs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 107. North America Somatostatin and Somatostatin Analogs Market Share Forecast by Country (2027-2032) Table 108. Europe Somatostatin and Somatostatin Analogs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 109. Europe Somatostatin and Somatostatin Analogs Sales by Country (2021-2026) & (K Units) Table 110. Europe Somatostatin and Somatostatin Analogs Sales Market Share by Country (2021-2026) Table 111. Europe Somatostatin and Somatostatin Analogs Sales Forecast by Country (2027-2032) & (K Units) Table 112. Europe Somatostatin and Somatostatin Analogs Sales Market Share Forecast by Country (2027-2032) Table 113. Europe Somatostatin and Somatostatin Analogs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 114. Europe Somatostatin and Somatostatin Analogs Market Size by Country (2021-2026) & (US$ Million) Table 115. Europe Somatostatin and Somatostatin Analogs Market Share by Country (2021-2026) Table 116. Europe Somatostatin and Somatostatin Analogs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 117. Europe Somatostatin and Somatostatin Analogs Market Share Forecast by Country (2027-2032) Table 118. Asia-Pacific Somatostatin and Somatostatin Analogs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 119. Asia-Pacific Somatostatin and Somatostatin Analogs Sales by Country (2021-2026) & (K Units) Table 120. Asia-Pacific Somatostatin and Somatostatin Analogs Sales Market Share by Country (2021-2026) Table 121. Asia-Pacific Somatostatin and Somatostatin Analogs Sales Forecast by Country (2027-2032) & (K Units) Table 122. Asia-Pacific Somatostatin and Somatostatin Analogs Sales Market Share Forecast by Country (2027-2032) Table 123. Asia-Pacific Somatostatin and Somatostatin Analogs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 124. Asia-Pacific Somatostatin and Somatostatin Analogs Market Size by Country (2021-2026) & (US$ Million) Table 125. Asia-Pacific Somatostatin and Somatostatin Analogs Market Share by Country (2021-2026) Table 126. Asia-Pacific Somatostatin and Somatostatin Analogs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 127. Asia-Pacific Somatostatin and Somatostatin Analogs Market Share Forecast by Country (2027-2032) Table 128. Latin America Somatostatin and Somatostatin Analogs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 129. Latin America Somatostatin and Somatostatin Analogs Sales by Country (2021-2026) & (K Units) Table 130. Latin America Somatostatin and Somatostatin Analogs Sales Market Share by Country (2021-2026) Table 131. Latin America Somatostatin and Somatostatin Analogs Sales Forecast by Country (2027-2032) & (K Units) Table 132. Latin America Somatostatin and Somatostatin Analogs Sales Market Share Forecast by Country (2027-2032) Table 133. Latin America Somatostatin and Somatostatin Analogs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 134. Latin America Somatostatin and Somatostatin Analogs Market Size by Country (2021-2026) & (US$ Million) Table 135. Latin America Somatostatin and Somatostatin Analogs Market Share by Country (2021-2026) Table 136. Latin America Somatostatin and Somatostatin Analogs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 137. Latin America Somatostatin and Somatostatin Analogs Market Share Forecast by Country (2027-2032) Table 138. Middle East and Africa Somatostatin and Somatostatin Analogs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 139. Middle East and Africa Somatostatin and Somatostatin Analogs Sales by Country (2021-2026) & (K Units) Table 140. Middle East and Africa Somatostatin and Somatostatin Analogs Sales Market Share by Country (2021-2026) Table 141. Middle East and Africa Somatostatin and Somatostatin Analogs Sales Forecast by Country (2027-2032) & (K Units) Table 142. Middle East and Africa Somatostatin and Somatostatin Analogs Sales Market Share Forecast by Country (2027-2032) Table 143. Middle East and Africa Somatostatin and Somatostatin Analogs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 144. Middle East and Africa Somatostatin and Somatostatin Analogs Market Size by Country (2021-2026) & (US$ Million) Table 145. Middle East and Africa Somatostatin and Somatostatin Analogs Market Share by Country (2021-2026) Table 146. Middle East and Africa Somatostatin and Somatostatin Analogs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 147. Middle East and Africa Somatostatin and Somatostatin Analogs Market Share Forecast by Country (2027-2032) Table 148. Key Raw Materials Table 149. Raw Materials Key Suppliers Table 150. Somatostatin and Somatostatin Analogs Distributors List Table 151. Somatostatin and Somatostatin Analogs Customers List Table 152. Research Programs/Design for This Report Table 153. Authors List of This Report Table 154. Secondary Sources Table 155. Primary Sources List of Figures Figure 1. Somatostatin and Somatostatin Analogs Image Figure 2. Global Somatostatin and Somatostatin Analogs Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Somatostatin and Somatostatin Analogs Market Size (2021-2032) & (US$ Million) Figure 4. Global Somatostatin and Somatostatin Analogs Sales (2021-2032) & (K Units) Figure 5. Octreotide Image Figure 6. Global Octreotide Sales YoY Growth (2021-2032) & (K Units) Figure 7. Lanreotide Image Figure 8. Global Lanreotide Sales YoY Growth (2021-2032) & (K Units) Figure 9. Pasireotide Image Figure 10. Global Pasireotide Sales YoY Growth (2021-2032) & (K Units) Figure 11. Other Image Figure 12. Global Other Sales YoY Growth (2021-2032) & (K Units) Figure 13. Global Somatostatin and Somatostatin Analogs Market Size Overview by Type (2021-2032) & (US$ Million) Figure 14. Global Somatostatin and Somatostatin Analogs Market Share by Type 2025 VS 2032 Figure 15. North America Somatostatin and Somatostatin Analogs Sales Market Share in Volume by Type in 2025 Figure 16. North America Somatostatin and Somatostatin Analogs Sales Market Share in Value by Type in 2025 Figure 17. Europe Somatostatin and Somatostatin Analogs Sales Market Share in Volume by Type in 2025 Figure 18. Europe Somatostatin and Somatostatin Analogs Sales Market Share in Value by Type in 2025 Figure 19. Asia-Pacific Somatostatin and Somatostatin Analogs Sales Market Share in Volume by Type in 2025 Figure 20. Asia-Pacific Somatostatin and Somatostatin Analogs Sales Market Share in Value by Type in 2025 Figure 21. Latin America Somatostatin and Somatostatin Analogs Sales Market Share in Volume by Type in 2025 Figure 22. Latin America Somatostatin and Somatostatin Analogs Sales Market Share in Value by Type in 2025 Figure 23. Middle East and Africa Somatostatin and Somatostatin Analogs Sales Market Share in Volume by Type in 2025 Figure 24. Middle East and Africa Somatostatin and Somatostatin Analogs Sales Market Share in Value by Type in 2025 Figure 25. Global Top 5 and 10 Somatostatin and Somatostatin Analogs Players Market Share by Revenue in 2025 Figure 26. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Hospital Image Figure 28. Global Hospital Sales YoY Growth (2021-2032) & (K Units) Figure 29. Pharmacy Image Figure 30. Global Pharmacy Sales YoY Growth (2021-2032) & (K Units) Figure 31. Other Image Figure 32. Global Other Sales YoY Growth (2021-2032) & (K Units) Figure 33. Global Somatostatin and Somatostatin Analogs Market Size Overview by Application (2021-2032) & (US$ Million) Figure 34. Global Somatostatin and Somatostatin Analogs Market Share by Application 2025 VS 2032 Figure 35. North America Somatostatin and Somatostatin Analogs Sales Market Share in Volume by Application in 2025 Figure 36. North America Somatostatin and Somatostatin Analogs Sales Market Share in Value by Application in 2025 Figure 37. Europe Somatostatin and Somatostatin Analogs Sales Market Share in Volume by Application in 2025 Figure 38. Europe Somatostatin and Somatostatin Analogs Sales Market Share in Value by Application in 2025 Figure 39. Asia-Pacific Somatostatin and Somatostatin Analogs Sales Market Share in Volume by Application in 2025 Figure 40. Asia-Pacific Somatostatin and Somatostatin Analogs Sales Market Share in Value by Application in 2025 Figure 41. Latin America Somatostatin and Somatostatin Analogs Sales Market Share in Volume by Application in 2025 Figure 42. Latin America Somatostatin and Somatostatin Analogs Sales Market Share in Value by Application in 2025 Figure 43. Middle East and Africa Somatostatin and Somatostatin Analogs Sales Market Share in Volume by Application in 2025 Figure 44. Middle East and Africa Somatostatin and Somatostatin Analogs Sales Market Share in Value by Application in 2025 Figure 45. North America Somatostatin and Somatostatin Analogs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 46. North America Somatostatin and Somatostatin Analogs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. North America Somatostatin and Somatostatin Analogs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. North America Somatostatin and Somatostatin Analogs Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Somatostatin and Somatostatin Analogs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 50. Europe Somatostatin and Somatostatin Analogs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Somatostatin and Somatostatin Analogs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Europe Somatostatin and Somatostatin Analogs Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Somatostatin and Somatostatin Analogs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 54. Asia-Pacific Somatostatin and Somatostatin Analogs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific Somatostatin and Somatostatin Analogs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Asia-Pacific Somatostatin and Somatostatin Analogs Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Somatostatin and Somatostatin Analogs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 58. Latin America Somatostatin and Somatostatin Analogs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Somatostatin and Somatostatin Analogs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Latin America Somatostatin and Somatostatin Analogs Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Somatostatin and Somatostatin Analogs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 62. Middle East and Africa Somatostatin and Somatostatin Analogs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa Somatostatin and Somatostatin Analogs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Middle East and Africa Somatostatin and Somatostatin Analogs Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. Somatostatin and Somatostatin Analogs Value Chain Figure 66. Key Raw Materials Price Figure 67. Manufacturing Cost Structure Figure 68. Somatostatin and Somatostatin Analogs Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Octreotide
  • Lanreotide
  • Pasireotide
  • Other
Applications
  • Hospital
  • Pharmacy
  • Other
Companies covered
  • Novartis
  • Pfizer
  • TianTaiShan
  • Ispen
  • HYBIO

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Somatostatin and Somatostatin Analogs Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Somatostatin and Somatostatin Analogs Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Somatostatin and Somatostatin Analogs Market by Type
  6. 1.3.1 Octreotide
  7. 1.3.2 Lanreotide
  8. 1.3.3 Pasireotide
  9. 1.3.4 Other
  10. 1.4 Global Somatostatin and Somatostatin Analogs Market Size by Type
  11. 1.4.1 Global Somatostatin and Somatostatin Analogs Market Size Overview by Type (2021-2032)
  12. 1.4.2 Global Somatostatin and Somatostatin Analogs Historic Market Size Review by Type (2021-2026)
  13. 1.4.3 Global Somatostatin and Somatostatin Analogs Forecasted Market Size by Type (2027-2032)
  14. 1.5 Key Regions Market Size by Type
  15. 1.5.1 North America Somatostatin and Somatostatin Analogs Sales Breakdown by Type (2021-2026)
  16. 1.5.2 Europe Somatostatin and Somatostatin Analogs Sales Breakdown by Type (2021-2026)
  17. 1.5.3 Asia-Pacific Somatostatin and Somatostatin Analogs Sales Breakdown by Type (2021-2026)
  18. 1.5.4 South America Somatostatin and Somatostatin Analogs Sales Breakdown by Type (2021-2026)
  19. 1.5.5 Middle East and Africa Somatostatin and Somatostatin Analogs Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Somatostatin and Somatostatin Analogs Industry Trends
  2. 2.2 Somatostatin and Somatostatin Analogs Industry Drivers
  3. 2.3 Somatostatin and Somatostatin Analogs Industry Opportunities and Challenges
  4. 2.4 Somatostatin and Somatostatin Analogs Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Somatostatin and Somatostatin Analogs Revenue (2021-2026)
  2. 3.2 Global Top Players by Somatostatin and Somatostatin Analogs Sales (2021-2026)
  3. 3.3 Global Top Players by Somatostatin and Somatostatin Analogs Price (2021-2026)
  4. 3.4 Global Somatostatin and Somatostatin Analogs Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Somatostatin and Somatostatin Analogs Major Company Production Sites & Headquarters
  6. 3.6 Global Somatostatin and Somatostatin Analogs Company, Product Type & Application
  7. 3.7 Global Somatostatin and Somatostatin Analogs Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Somatostatin and Somatostatin Analogs Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Somatostatin and Somatostatin Analogs Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Somatostatin and Somatostatin Analogs Tier 1, Tier 2, and Tier 3
4 Somatostatin and Somatostatin Analogs Regional Status and Outlook
  1. 4.1 Global Somatostatin and Somatostatin Analogs Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Somatostatin and Somatostatin Analogs Historic Market Size by Region
  3. 4.2.1 Global Somatostatin and Somatostatin Analogs Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Somatostatin and Somatostatin Analogs Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Somatostatin and Somatostatin Analogs Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Somatostatin and Somatostatin Analogs Forecasted Market Size by Region
  7. 4.3.1 Global Somatostatin and Somatostatin Analogs Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Somatostatin and Somatostatin Analogs Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Somatostatin and Somatostatin Analogs Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Somatostatin and Somatostatin Analogs by Application
  1. 5.1 Somatostatin and Somatostatin Analogs Market by Application
  2. 5.1.1 Hospital
  3. 5.1.2 Pharmacy
  4. 5.1.3 Other
  5. 5.2 Global Somatostatin and Somatostatin Analogs Market Size by Application
  6. 5.2.1 Global Somatostatin and Somatostatin Analogs Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Somatostatin and Somatostatin Analogs Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Somatostatin and Somatostatin Analogs Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Somatostatin and Somatostatin Analogs Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Somatostatin and Somatostatin Analogs Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Somatostatin and Somatostatin Analogs Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Somatostatin and Somatostatin Analogs Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Somatostatin and Somatostatin Analogs Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Novartis
  2. 6.1.1 Novartis Company Information
  3. 6.1.2 Novartis Business Overview
  4. 6.1.3 Novartis Somatostatin and Somatostatin Analogs Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Novartis Somatostatin and Somatostatin Analogs Product Portfolio
  6. 6.1.5 Novartis Recent Developments
  7. 6.2 Pfizer
  8. 6.2.1 Pfizer Company Information
  9. 6.2.2 Pfizer Business Overview
  10. 6.2.3 Pfizer Somatostatin and Somatostatin Analogs Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Pfizer Somatostatin and Somatostatin Analogs Product Portfolio
  12. 6.2.5 Pfizer Recent Developments
  13. 6.3 TianTaiShan
  14. 6.3.1 TianTaiShan Company Information
  15. 6.3.2 TianTaiShan Business Overview
  16. 6.3.3 TianTaiShan Somatostatin and Somatostatin Analogs Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 TianTaiShan Somatostatin and Somatostatin Analogs Product Portfolio
  18. 6.3.5 TianTaiShan Recent Developments
  19. 6.4 Ispen
  20. 6.4.1 Ispen Company Information
  21. 6.4.2 Ispen Business Overview
  22. 6.4.3 Ispen Somatostatin and Somatostatin Analogs Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Ispen Somatostatin and Somatostatin Analogs Product Portfolio
  24. 6.4.5 Ispen Recent Developments
  25. 6.5 HYBIO
  26. 6.5.1 HYBIO Company Information
  27. 6.5.2 HYBIO Business Overview
  28. 6.5.3 HYBIO Somatostatin and Somatostatin Analogs Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 HYBIO Somatostatin and Somatostatin Analogs Product Portfolio
  30. 6.5.5 HYBIO Recent Developments
7 North America by Country
  1. 7.1 North America Somatostatin and Somatostatin Analogs Sales by Country
  2. 7.1.1 North America Somatostatin and Somatostatin Analogs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Somatostatin and Somatostatin Analogs Sales by Country (2021-2026)
  4. 7.1.3 North America Somatostatin and Somatostatin Analogs Sales Forecast by Country (2027-2032)
  5. 7.2 North America Somatostatin and Somatostatin Analogs Market Size by Country
  6. 7.2.1 North America Somatostatin and Somatostatin Analogs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Somatostatin and Somatostatin Analogs Market Size by Country (2021-2026)
  8. 7.2.3 North America Somatostatin and Somatostatin Analogs Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Somatostatin and Somatostatin Analogs Sales by Country
  2. 8.1.1 Europe Somatostatin and Somatostatin Analogs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Somatostatin and Somatostatin Analogs Sales by Country (2021-2026)
  4. 8.1.3 Europe Somatostatin and Somatostatin Analogs Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Somatostatin and Somatostatin Analogs Market Size by Country
  6. 8.2.1 Europe Somatostatin and Somatostatin Analogs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Somatostatin and Somatostatin Analogs Market Size by Country (2021-2026)
  8. 8.2.3 Europe Somatostatin and Somatostatin Analogs Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Somatostatin and Somatostatin Analogs Sales by Country
  2. 9.1.1 Asia-Pacific Somatostatin and Somatostatin Analogs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Somatostatin and Somatostatin Analogs Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Somatostatin and Somatostatin Analogs Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Somatostatin and Somatostatin Analogs Market Size by Country
  6. 9.2.1 Asia-Pacific Somatostatin and Somatostatin Analogs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Somatostatin and Somatostatin Analogs Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Somatostatin and Somatostatin Analogs Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Somatostatin and Somatostatin Analogs Sales by Country
  2. 10.1.1 South America Somatostatin and Somatostatin Analogs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Somatostatin and Somatostatin Analogs Sales by Country (2021-2026)
  4. 10.1.3 South America Somatostatin and Somatostatin Analogs Sales Forecast by Country (2027-2032)
  5. 10.2 South America Somatostatin and Somatostatin Analogs Market Size by Country
  6. 10.2.1 South America Somatostatin and Somatostatin Analogs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Somatostatin and Somatostatin Analogs Market Size by Country (2021-2026)
  8. 10.2.3 South America Somatostatin and Somatostatin Analogs Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Somatostatin and Somatostatin Analogs Sales by Country
  2. 11.1.1 Middle East and Africa Somatostatin and Somatostatin Analogs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Somatostatin and Somatostatin Analogs Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Somatostatin and Somatostatin Analogs Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Somatostatin and Somatostatin Analogs Market Size by Country
  6. 11.2.1 Middle East and Africa Somatostatin and Somatostatin Analogs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Somatostatin and Somatostatin Analogs Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Somatostatin and Somatostatin Analogs Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Somatostatin and Somatostatin Analogs Value Chain Analysis
  2. 12.1.1 Somatostatin and Somatostatin Analogs Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Somatostatin and Somatostatin Analogs Production Mode & Process
  7. 12.2 Somatostatin and Somatostatin Analogs Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Somatostatin and Somatostatin Analogs Distributors
  10. 12.2.3 Somatostatin and Somatostatin Analogs Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst